KDM5A and acute myeloid leukemia: Paralleling reports from solid cancers, Garcia and colleagues found that the chemo-resistant AML cell lines Molm13 and Jurkat could be re-sensitized to AZD1775 treatment [114,115] by knockdown of KDM5A, resulting in cell death.